Introduction: Endometrial cancer (EC) is the sixth most common cancer among women worldwide and ranks as the fourth most common cancer in women in the UK, and sixth most common cause of death among women in the United States, with approximately 9,700 new cases diagnosed annually (1,2). Platinum-based chemotherapy, increasingly combined with immune